Posts by: Patricia Inacio, PhD

News

A new study entitled “HUWE1 Ubiquitylates and Degrades the RAC Activator TIAM1 Promoting Cell-Cell Adhesion Disassembly, Migration, and Invasion” identified the E3 ligase HUWE1 as an important regulator of the dissemination ... Read more

December 30, 2014December 30, 2014

Dietary Habits Can Expose Lung Cancer Vulnerabilities

News

A recent study entitled “Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis” revealed a surprising beneficial role of high-calorie-diet intake in limiting the proliferation of lung-tumors, driven by KRAS mutation, when ... Read more

December 18, 2014December 18, 2014

Smoking Remains Responsible For High Number Of Cancer Deaths In U.S.

News

A new study entitled “What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking?” reports that cigarrete smoking is still a leading cause of cancer ... Read more

December 9, 2014December 9, 2014

Study Proves VolitionRx’s NuQ Test Effective For Lung Cancer Detection in Blood And Sputum

News

VolitionRx Limited will present recent results from its pilot lung cancer study at the Science for Business BioWin Day 2014, in Louvain-la-Neuve, Belgium. Lung cancers are currently diagnosed when patients exhibit symptoms of impaired ... Read more

October 3, 2014October 3, 2014

AstraZeneca’s Iressa Receives EU Label Update For Lung Cancer Treatment

News

AstraZeneca announced a Type II update to the European label for Iressa (gefitinib) that allows doctors to identify suitable lung cancer patients for treatment with this drug even in the absence ... Read more

October 1, 2014October 1, 2014

Nivolumab Lung Cancer Drug EMA Validation for Marketing Authorization Application

News

The first immune-checkpoint targeting drug for non-small cell lung cancer (NSCLC), Opdivo (nivolumab), was just validated by the European Medicines Agency (EMA) to review its Marketing Authorization Application (MAA), according to ... Read more

September 25, 2014September 25, 2014

Small Cell Lung Cancer Features Novel Oncogenic RET Mutation, According To New Research

Lung cancer News, News

A team of scientists from Case Western University recently discovered a somatic mutation on oncogene RET in small cell lung cancer (SCLC) tumors that is responsible for tumor growth via activation of ... Read more

September 19, 2014May 27, 2015

Boehringer Ingelheim and CureVac Announce Collaboration to Develop Lung Cancer Immunotherapy

Lung cancer News, News

A new agreement to investigate a therapeutic mRNA vaccine for the treatment of lung cancer was announced today between Boehringer Ingelheim and CureVac, a leader company in mRNA-based drug development. ... Read more